Diagnostic delay in children with inflammatory bowel disease in the German-Austrian patient registry CEDATA-GPGE

Maren Leiz1, Melanie Knorr2, Kilson Moon2

  • 1Institute for Community Medicine, University Medicine, Greifswald, Germany. maren.leiz@jade-hs.de.

Scientific Reports
|December 8, 2022
PubMed

Insights

Diagnosing pediatric inflammatory bowel disease (PIBD) takes longer for Crohn's disease (CD) than Ulcerative colitis (UC). Increased awareness of common symptoms like abdominal pain is crucial for earlier PIBD diagnosis.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Epidemiology

Background:

  • Pediatric-onset inflammatory bowel disease (PIBD) incidence is increasing globally.
  • Delayed diagnosis of PIBD negatively impacts quality of life and increases complication rates.

Purpose of the Study:

  • To investigate the diagnostic delay in pediatric patients with inflammatory bowel disease (PIBD).
  • To identify factors that influence the time to diagnosis in PIBD.

Main Methods:

  • Analysis of data from the German-Austrian patient registry CEDATA-GPGE (2014-2018).
  • Inclusion of 456 children and adolescents diagnosed with PIBD, categorized into Crohn's disease (CD) and Ulcerative colitis (UC).

Main Results:

  • Median diagnostic delay was 4.1 months for CD and 2.4 months for UC (p=0.01), with UC diagnosed significantly earlier (p<0.001).
  • Factors like nighttime abdominal pain and video capsule endoscopy use were associated with diagnostic delay.
  • Diagnostic delay showed improvement over time in participating centers.

Conclusions:

  • Ulcerative colitis (UC) in children has a shorter diagnostic delay compared to Crohn's disease (CD).
  • Continued efforts to raise awareness for common PIBD symptoms, such as abdominal pain, are necessary for timely diagnosis.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
387
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
337
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
115
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
224
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
169
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
449